GRCh37/hg19 20q13.33(chr20:61530581-61911114)x1 AND See cases

Germline classification:: Likely benign (1 submission)
Last evaluated:: May 5, 2014
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000512342.2

Allele description [Variation Report for GRCh37/hg19 20q13.33(chr20:61530581-61911114)x1]

GRCh37/hg19 20q13.33(chr20:61530581-61911114)x1

Genes:

ARFGAP1:ADP ribosylation factor GTPase activating protein 1 [Gene - OMIM - HGNC]
GID8:GID complex subunit 8 homolog [Gene - OMIM - HGNC]
YTHDF1:YTH N6-methyladenosine RNA binding protein 1 [Gene - OMIM - HGNC]
BIRC7:baculoviral IAP repeat containing 7 [Gene - OMIM - HGNC]
BHLHE23:basic helix-loop-helix family member e23 [Gene - OMIM - HGNC]
DIDO1:death inducer-obliterator 1 [Gene - OMIM - HGNC]
HAR1A:highly accelerated region 1A [Gene - OMIM - HGNC]
HAR1B:highly accelerated region 1B [Gene - OMIM - HGNC]
NKAIN4:sodium/potassium transporting ATPase interacting 4 [Gene - OMIM - HGNC]
SLC17A9:solute carrier family 17 member 9 [Gene - OMIM - HGNC]

Variant type:

copy number loss

Cytogenetic location:

20q13.33

Genomic location:

Chr20: 61530581 - 61911114 (on Assembly GRCh37)

Preferred name:

GRCh37/hg19 20q13.33(chr20:61530581-61911114)x1

HGVS:

NC_000020.10:g.(?_61530581)_(61911114_?)del

Links:

dbVar: nssv13652919; dbVar: nsv2776243

Observations:

Condition(s)

Name:: See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000585639	ISCA site 1 See additional submitters International Standards For Cytogenomic Arrays Consortium (ISCA)	no assertion criteria provided	Likely benign (May 5, 2014)	not provided	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000585639

ISCA site 1

See additional submitters

no assertion criteria provided

Likely benign
(May 5, 2014)

not provided

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	not provided	yes	1	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]

PMID:: 20466091
PMCID:: PMC2869000

Details of each submission

From ISCA site 1, SCV000585639.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	not provided	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

Last Updated: Apr 23, 2022

ClinVar

Relating variation to medicine